These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33753560)

  • 1. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas: a clinical follow-up study.
    Koh SS; Lau SK; Roehmholdt BF; Cassarino DS
    J Clin Pathol; 2022 Jan; 75(1):68-70. PubMed ID: 33753560
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas.
    Koh SS; Roehmholdt BF; Cassarino DS
    J Cutan Pathol; 2018 Dec; 45(12):891-896. PubMed ID: 30178478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms.
    McBride JD; McAfee JL; Piliang M; Bergfeld WF; Fernandez AP; Ronen S; Billings SD; Ko JS
    J Cutan Pathol; 2022 Mar; 49(3):220-230. PubMed ID: 34476825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma.
    Oaxaca G; Billings SD; Ko JS
    J Cutan Pathol; 2020 Sep; 47(9):815-823. PubMed ID: 32330325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study.
    Mesbah Ardakani N; Singh S; Thomas C; Van Vliet C; Harvey NT; Calonje JE; Wood BA
    Am J Dermatopathol; 2021 Mar; 43(3):182-190. PubMed ID: 32649342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevoid melanoma.
    Diwan AH; Lazar AJ
    Clin Lab Med; 2011 Jun; 31(2):243-53. PubMed ID: 21549238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16INK4A expression in malignant melanomas with or without a contiguous naevus remnant: a clue to their divergent pathogenesis?
    Winnepenninckx V; van den Oord JJ
    Melanoma Res; 2004 Aug; 14(4):321-2. PubMed ID: 15305164
    [No Abstract]   [Full Text] [Related]  

  • 10. p15 Expression Differentiates Nevus from Melanoma.
    Taylor LA; O'Day C; Dentchev T; Hood K; Chu EY; Ridky TW; Seykora JT
    Am J Pathol; 2016 Dec; 186(12):3094-3099. PubMed ID: 27855847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry.
    Sparrow LE; Eldon MJ; English DR; Heenan PJ
    Am J Dermatopathol; 1998 Jun; 20(3):255-61. PubMed ID: 9650698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors.
    Mert M; Bozdogan O; Bozdogan N; Gamsızkan M; Safali M
    Am J Dermatopathol; 2024 Oct; 46(10):653-662. PubMed ID: 38916203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
    See SHC; Finkelman BS; Yeldandi AV
    Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.
    de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; de Almeida OP
    Head Neck Pathol; 2012 Sep; 6(3):297-304. PubMed ID: 22311377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma.
    Ritter A; Tronnier M; Vaske B; Mitteldorf C
    Arch Dermatol Res; 2018 May; 310(4):329-342. PubMed ID: 29417221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 and p16 Expression in Blue Nevi and Malignant Melanoma.
    Donigan JM; De Luca J; Lum C
    Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):91-94. PubMed ID: 26766120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy.
    Jackett LA; Colebatch AJ; Rawson RV; Ferguson PM; Thompson JF; McCarthy SW; Wilmott JS; Scolyer RA
    Am J Surg Pathol; 2020 Mar; 44(3):357-367. PubMed ID: 31743128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of elastin immunostain improves the evaluation of melanomas associated with nevi.
    Kamino H; Tam S; Tapia B; Toussaint S
    J Cutan Pathol; 2009 Aug; 36(8):845-52. PubMed ID: 19032378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
    McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
    J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.
    Ghiorzo P; Villaggio B; Sementa AR; Hansson J; Platz A; Nicoló G; Spina B; Canepa M; Palmer JM; Hayward NK; Bianchi-Scarrà G
    Hum Pathol; 2004 Jan; 35(1):25-33. PubMed ID: 14745721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.